CLNN - Clene Inc.
5.355
0.055 1.027%
Share volume: 41,126
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$5.30
0.06
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-08-2024 | 08-07-2024 | 11-13-2024 | 03-24-2025 | 05-07-2025 | 11-13-2025 | |
| Total revenue | 73.000 K | 91.000 K | 87.000 K | 91.000 K | 81.000 K | 15.000 K | |
| Cost of revenue | 16.000 K | 18.000 K | 18.000 K | 18.000 K | 20.000 K | 0.000 | |
| Gross profit | 57.000 K | 73.000 K | 69.000 K | 73.000 K | 61.000 K | 15.000 K | |
| 28.07% | -5.48% | 5.80% | -16.44% | -75.41% | |||
| Operating expenses | 9.289 M | 7.464 M | 7.884 M | 8.728 M | 4.137 M | 5.663 M | |
| Selling general and admin | 3.420 M | 3.314 M | 3.413 M | 3.160 M | 2.656 M | 2.150 M | |
| Research and development | 5.869 M | 4.150 M | 4.471 M | 5.568 M | 1.481 M | 3.513 M | |
| Total expenses | 9.289 M | 7.464 M | 7.884 M | 8.728 M | 4.137 M | 5.663 M | |
| -19.65% | 5.63% | 10.71% | -52.60% | 36.89% | |||
| Operating income | -9.232 M | -7.391 M | -7.815 M | -8.655 M | -4.076 M | -5.648 M | |
| Ebit | -10.195 M | -5.772 M | -7.091 M | -12.928 M | -224.000 K | -8.168 M | |
| Pretax income | -11.080 M | -6.785 M | -7.986 M | -13.549 M | -751.000 K | -8.777 M | |
| -38.76% | 17.70% | 69.66% | -94.46% | 1,068.71% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -11.080 M | -6.785 M | -7.986 M | -13.549 M | -751.000 K | -8.777 M | |
| 38.76% | -17.70% | -69.66% | 94.46% | -1,068.71% |